IFP Advisors’s Enzo Biochem, Inc. ENZ Stock Holding History

IFP Advisors’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-8,000	Closed	-$88K	–	4237
2017 Q2	$88K	Sell	8,000 -1,500	-16%	-$14K	﹤0.01%	1604
2017 Q1	$80K	Buy	9,500 +5,500	+138%	+$38.7K	﹤0.01%	1649
2016 Q4	$28K	Hold	4,000	–	–	﹤0.01%	2250
2016 Q3	$20K	Buy	+4,000	New	+$23.9K	﹤0.01%	2406
2016 Q1	–	Sell	-3,350	Closed	-$15K	–	3518
2015 Q4	$15K	Buy	+3,350	New	+$14.1K	﹤0.01%	2348

Other funds holding ENZ

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EGA

Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

IFP Advisors's ENZ Position: Q3 2017 in Review

IFP Advisors sold out of Enzo Biochem, Inc. (ENZ) in Q3 2017, closing a stake of 8,000 shares — an estimated $88K sold.

IFP Advisors first reported a position in ENZ in Q4 2015 and held it in 5 quarters. The position peaked at $88K in Q2 2017. 116 funds tracked by Wall St. Rank hold ENZ as of Q3 2017.

IFP Advisors reported no remaining Enzo Biochem, Inc. position as of Q3 2017 after selling out during the quarter.
IFP Advisors sold 8,000 Enzo Biochem, Inc. shares in Q3 2017, an estimated $88K.
IFP Advisors first reported a position in Enzo Biochem, Inc. in Q4 2015 and held it in 5 quarters.
IFP Advisors's Enzo Biochem, Inc. position peaked at $88K in Q2 2017.
116 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q3 2017.

Based on IFP Advisors's 13F filing for Q3 2017, filed 30 Oct 2017.